MeSH term
Frequency | Condition_Probility | Adult | 5 | 0.0 |
Alleles | 16 | 0.0 |
Child | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 5 | 1.0 |
English Abstract | 2 | 0.0 |
Female | 39 | 0.0 |
Humans | 52 | 0.0 |
Male | 28 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Receptor, IGF Type 2/*genetics | 18 | 62.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Colorectal Neoplasms/*genetics | 2 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
*Microsatellite Repeats | 3 | 1.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Animals | 27 | 0.0 |
Binding Sites | 5 | 0.0 |
Comparative Study | 5 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Species Specificity | 5 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Mutation | 3 | 0.0 |
Placenta/metabolism | 3 | 1.0 |
Protein Binding | 2 | 0.0 |
Rats | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Cell Division | 4 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Mice | 22 | 0.0 |
Receptor, IGF Type 2/genetics/*physiology | 2 | 100.0 |
Transplantation, Heterologous | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Genotype | 3 | 0.0 |
Pregnancy | 7 | 0.0 |
*Genomic Imprinting | 10 | 3.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mothers | 3 | 3.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Genomic Imprinting/*genetics | 7 | 9.0 |
Insulin-Like Growth Factor II/genetics | 2 | 2.0 |
Mutation/genetics | 2 | 0.0 |
Pedigree | 3 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
Middle Aged | 4 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Genomic Imprinting | 2 | 1.0 |
Placenta/*metabolism | 3 | 1.0 |
Pregnancy Trimester, First | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Chromosomes, Human, Pair 6/*genetics | 2 | 1.0 |
Insulin/*blood | 2 | 1.0 |
Phenotype | 4 | 0.0 |
Brain/metabolism | 2 | 0.0 |
*DNA Methylation | 4 | 0.0 |
Fetus | 2 | 0.0 |
Genomic Imprinting/*physiology | 2 | 33.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Cohort Studies | 2 | 0.0 |
Aged | 2 | 0.0 |
DNA Repair/*genetics | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
CpG Islands | 3 | 1.0 |
Genetic Markers | 3 | 0.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
CpG Islands/genetics | 3 | 2.0 |
Insulin-Like Growth Factor II/*genetics | 4 | 2.0 |
Introns/genetics | 3 | 0.0 |
Muscle Proteins/genetics | 2 | 2.0 |
*RNA, Untranslated | 2 | 1.0 |
Receptor, IGF Type 2/genetics | 3 | 12.0 |
Insulin-Like Growth Factor II/*metabolism | 4 | 15.0 |
Loss of Heterozygosity | 2 | 0.0 |
Mannosephosphates/*metabolism | 3 | 42.0 |
Neoplasms/*genetics | 2 | 0.0 |
Insulin-Like Growth Factor I/*biosynthesis/genetics | 3 | 50.0 |
Insulin-Like Growth Factor II/*biosynthesis/genetics | 3 | 21.0 |
Mice, Transgenic | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Cell Line | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Mice/*genetics | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
DNA Methylation | 6 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Receptor, IGF Type 1/*biosynthesis/genetics | 2 | 50.0 |
Receptor, IGF Type 2/*biosynthesis/genetics | 2 | 100.0 |
Breast Neoplasms/*genetics/pathology | 3 | 1.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Chimera | 2 | 1.0 |
Methylation | 2 | 0.0 |
Genome, Human | 2 | 0.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Receptor, IGF Type 2 | 2 | 28.0 |
Receptors, Cell Surface/*genetics | 2 | 0.0 |
